CAR-T Therapy for Second-Line Treatment in High-Risk Multiple Myeloma
Panelists discuss how multiple myeloma patients and healthcare providers navigate the comprehensive CAR-T therapy journey, from initial diagnosis through treatment selection, therapy administration, and long-term follow-up care, while sharing clinical insights and personal experiences about treatment outcomes, side effect management, and quality of life improvements.
EP. 1: A High-Risk Myeloma Patient’s Path to CAR T: Personal and Clinical Perspectives
December 5th 2024Panelists discuss how the symptoms of a patient with multiple myeloma led to their initial diagnosis and the progression of various treatments they underwent before becoming a candidate for CAR T therapy.
EP. 2: Behind the Scenes: Patient Education and Decision-Making for CAR T
December 5th 2024Panelists discuss how health care providers engage in vital conversations with patients about CAR T therapy, focusing on comprehensive education, emotional support, and clear communication about the treatment journey ahead.
